Disease Info Card

Leydig Cell Tumor

Information about Leydig Cell Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Leydig Cell Tumor

Most recent studies have shown that Leydig Cell Tumor shares some biological mechanisms with adenoma, carcinoma, dysgerminoma, granulosa-cell-tumor, gynecomastia, hyperplasia, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, neoplasms-experimental, ovarian-neoplasm, precocious-puberty, seminoma, sertoli-cell-tumor, sertoli-leydig-cell-tumor, teratoma, testicular-leydig-cell-tumor, testicular-neoplasms, virilism.

Among the many pathways, these few ones have gauged particular interests from scientists studying Leydig Cell Tumor, and have been seen in publications frequently: Aging, Androgen Secretion, Angiogenesis, Bone Resorption, Cell Cycle, Cell Growth, Cell Proliferation, Cholesterol Transport, Enucleation, Excretion, Hormone Secretion, Localization, Pathogenesis, Progesterone Secretion, Protein Phosphorylation, Secretion, Spermatogenesis, Testosterone Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Leydig Cell Tumor, such as AFP, AR, BRD2, CEL, CYP19A1, DBT, EGF, ESR1, LCT, LHCGR, NR5A1, PLOD1, POMC, PRL, PTH, PTHLH, STAR, TSPO, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.